DISEASE AREA COMMERCIAL LEADER
Albert Lee is Vice President, Disease Area Commercial Leader, Gastroenterology for the Immunology Therapeutic Area of Janssen Global Services. In this role, he is responsible for developing and executing the end-to-end strategy to discover and develop new therapeutics for disease areas within Gastroenterology.
Albert has spent more than 20 years at Johnson & Johnson, in roles of increasing responsibility including sales, marketing and general management across different geographies and franchises.
Prior to his current role, he was the Managing Director for One J&J Singapore and he led and executed on the growth strategy for four years across Pharm, Medical Device and Consumer sectors for the enterprise. This included building new capabilities in key account management, government affairs and market access. In 2012, he led the integration of the DePuy Synthes across six countries (Thailand, Malaysia, Singapore, Vietnam, Indonesia and Philippines) as the General Manager of Southeast Asia.
From 2010 to 2012, he was the Association of Southeast Asian Nations (ASEAN) Franchise Director for DePuy and Country Director of Singapore. In 2007, he was selected to participate in an International Development Program in the US and UK, before moving to Thailand in 2008, as Franchise Director.
In recognition of his leadership and passionate involvement in the healthcare industry, Albert was elected Chairman for Medical Technology Industry Group by Singapore Manufacturing Federation (SMF MTIG), where he has served since 2014. Albert is also on the Board of Directors of Singapore Association of Pharmaceuticals Industries (SAPI) and on the Alumni Advisory Board of Nanyang Technological University Business School. He is also a Member of Medical Devices Industry Policy Review Working Group, Health Sciences Authority (HSA).
Albert holds a Bachelor of Business degree in Marketing from Nanyang Technological University in Singapore and earned his MBA from Duke University in Durham, North Carolina.